K. Namberger

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor

R. Greil, T. Hartmann, T. Girbl, 2014, Transfusion.

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

M. Pichler, F. Berr, C. Mayr, 2015, Molecular medicine reports.

Perinasal dermatitis due to a local plasmacytoma with vicinal nodular AL𝛌 amyloid

M. Laimer, R. Linke, H. Hintner, 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

An uncommon cause of anaemia: Sheehan's syndrome

R. Greil, T. Melchardt, A. Egle, 2010, Wiener klinische Wochenschrift.

Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.

C. Massone, L. Pleyer, R. Greil, 2009, Acta dermato-venereologica.

Plerixafor and granulocyte–colony‐stimulating factor (G‐CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G‐CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program

P. Neumeister, H. Greinix, P. Kalhs, 2011, Transfusion.

The Role of Imaging in Malignant Lymphoma: A Critical View on PET Scanning in Current Clinical Practice

K. Namberger, R. Greil, 2006 .

Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme

R. Greil, B. Mlineritsch, C. Hauser-kronberger, 2007, Breast Cancer Research and Treatment.

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

R. Greil, B. Mlineritsch, R. Reitsamer, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A case of long‐term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab‐refractory chronic lymphocytic leukaemia with deletion 17p

R. Greil, T. Melchardt, B. Krause, 2013, European journal of haematology.